.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Johnson and Johnson
Colorcon
Merck
US Department of Justice
US Army
Medtronic
Deloitte
Chinese Patent Office
Citi

Generated: December 12, 2017

DrugPatentWatch Database Preview

MEFOXIN Drug Profile

« Back to Dashboard

When do Mefoxin patents expire, and when can generic versions of Mefoxin launch?

Mefoxin is a drug marketed by Mylan Institutional and Merck and is included in four NDAs.

The generic ingredient in MEFOXIN is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Drug patent expirations by year for MEFOXIN

Medical Subject Heading (MeSH) Categories for MEFOXIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mylan InstitutionalMEFOXINcefoxitin sodiumINJECTABLE;INJECTION062757-001Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MerckMEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINERcefoxitin sodiumINJECTABLE;INJECTION050581-004Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalMEFOXINcefoxitin sodiumINJECTABLE;INJECTION050517-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalMEFOXIN IN PLASTIC CONTAINERcefoxitin sodiumINJECTABLE;INJECTION063182-001Jan 25, 1993RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalMEFOXINcefoxitin sodiumINJECTABLE;INJECTION050517-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalMEFOXINcefoxitin sodiumINJECTABLE;INJECTION062757-002Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MerckMEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINERcefoxitin sodiumINJECTABLE;INJECTION050581-003Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalMEFOXINcefoxitin sodiumINJECTABLE;INJECTION050517-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
MerckMEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERcefoxitin sodiumINJECTABLE;INJECTION050581-002Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
MerckMEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERcefoxitin sodiumINJECTABLE;INJECTION050581-001Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Covington
Cipla
QuintilesIMS
Moodys
Merck
Chubb
Healthtrust
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot